Cargando…
Cancer: evolutionary, genetic and epigenetic aspects
There exist two paradigms about the nature of cancer. According to the generally accepted one, cancer is a by-product of design limitations of a multi-cellular organism (Greaves, Nat Rev Cancer 7:213–221, 2007). The essence of the second resides in the question “Does cancer kill the individual and s...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365664/ https://www.ncbi.nlm.nih.gov/pubmed/22704202 http://dx.doi.org/10.1007/s13148-010-0010-6 |
_version_ | 1782234684988588032 |
---|---|
author | Lichtenstein, Anatoly V. |
author_facet | Lichtenstein, Anatoly V. |
author_sort | Lichtenstein, Anatoly V. |
collection | PubMed |
description | There exist two paradigms about the nature of cancer. According to the generally accepted one, cancer is a by-product of design limitations of a multi-cellular organism (Greaves, Nat Rev Cancer 7:213–221, 2007). The essence of the second resides in the question “Does cancer kill the individual and save the species?” (Sommer, Hum Mutat 3:166–169, 1994). Recent data on genetic and epigenetic mechanisms of cell transformation summarized in this review support the latter point of view, namely that carcinogenesis is an evolutionary conserved phenomenon—a programmed death of an organism. It is assumed that cancer possesses an important function of altruistic nature: as a mediator of negative selection, it serves to preserve integrity of species gene pool and to mediate its evolutionary adjustment. Cancer fulfills its task due apparently to specific killer function, understanding mechanism of which may suggest new therapeutic strategy. |
format | Online Article Text |
id | pubmed-3365664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-33656642012-06-02 Cancer: evolutionary, genetic and epigenetic aspects Lichtenstein, Anatoly V. Clin Epigenetics Review There exist two paradigms about the nature of cancer. According to the generally accepted one, cancer is a by-product of design limitations of a multi-cellular organism (Greaves, Nat Rev Cancer 7:213–221, 2007). The essence of the second resides in the question “Does cancer kill the individual and save the species?” (Sommer, Hum Mutat 3:166–169, 1994). Recent data on genetic and epigenetic mechanisms of cell transformation summarized in this review support the latter point of view, namely that carcinogenesis is an evolutionary conserved phenomenon—a programmed death of an organism. It is assumed that cancer possesses an important function of altruistic nature: as a mediator of negative selection, it serves to preserve integrity of species gene pool and to mediate its evolutionary adjustment. Cancer fulfills its task due apparently to specific killer function, understanding mechanism of which may suggest new therapeutic strategy. Springer-Verlag 2010-09-14 /pmc/articles/PMC3365664/ /pubmed/22704202 http://dx.doi.org/10.1007/s13148-010-0010-6 Text en © Springer-Verlag 2010 |
spellingShingle | Review Lichtenstein, Anatoly V. Cancer: evolutionary, genetic and epigenetic aspects |
title | Cancer: evolutionary, genetic and epigenetic aspects |
title_full | Cancer: evolutionary, genetic and epigenetic aspects |
title_fullStr | Cancer: evolutionary, genetic and epigenetic aspects |
title_full_unstemmed | Cancer: evolutionary, genetic and epigenetic aspects |
title_short | Cancer: evolutionary, genetic and epigenetic aspects |
title_sort | cancer: evolutionary, genetic and epigenetic aspects |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3365664/ https://www.ncbi.nlm.nih.gov/pubmed/22704202 http://dx.doi.org/10.1007/s13148-010-0010-6 |
work_keys_str_mv | AT lichtensteinanatolyv cancerevolutionarygeneticandepigeneticaspects |